RBC Europe’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $217K | Hold |
2,570
| – | – | 0.01% | 199 |
|
|
2022
Q1 | $226K | Hold |
2,570
| – | – | 0.01% | 212 |
|
|
2021
Q4 | $225K | Sell |
2,570
-200
| -7% | -$17.5K | 0.01% | 217 |
|
|
2021
Q3 | $227K | Hold |
2,770
| – | – | 0.01% | 281 |
|
|
2021
Q2 | $253K | Buy |
2,770
+270
| +11% | +$24.6K | 0.01% | 283 |
|
|
2021
Q1 | $214K | Hold |
2,500
| – | – | 0.01% | 286 |
|
|
2020
Q4 | $236K | Hold |
2,500
| – | – | 0.01% | 256 |
|
|
2020
Q3 | $217K | Hold |
2,500
| – | – | 0.01% | 246 |
|
|
2020
Q2 | $218K | Hold |
2,500
| – | – | 0.02% | 229 |
|
|
2020
Q1 | $206K | Hold |
2,500
| – | – | 0.02% | 206 |
|
|
2019
Q4 | $237K | Hold |
2,500
| – | – | 0.02% | 230 |
|
|
2019
Q3 | $217K | Buy |
2,500
+400
| +19% | +$34.8K | 0.02% | 237 |
|
|
2019
Q2 | $192K | Sell |
2,100
-244
| -10% | -$22.3K | 0.02% | 252 |
|
|
2019
Q1 | $202K | Sell |
2,344
-167
| -7% | -$14.4K | 0.02% | 239 |
|
|
2018
Q4 | $193K | Sell |
2,511
-781
| -24% | -$60.1K | 0.03% | 225 |
|
|
2018
Q3 | $254K | Hold |
3,292
| – | – | 0.03% | 215 |
|
|
2018
Q2 | $223K | Hold |
3,292
| – | – | 0.03% | 233 |
|
|
2018
Q1 | $239K | Hold |
3,292
| – | – | 0.03% | 222 |
|
|
2017
Q4 | $248K | Sell |
3,292
-397
| -11% | -$29.9K | 0.03% | 226 |
|
|
2017
Q3 | $284K | Buy |
+3,689
| New | +$284K | 0.04% | 206 |
|